Antibody responses to antigenic targets of recent exposure are associated with low-density parasitemia in controlled human plasmodium falciparum infections
The majority of malaria infections in low transmission settings remain undetectable by conventional diagnostics. A powerful model to identify antibody responses that allow accurate detection of recent exposure to low-density infections is controlled human malaria infection (CHMI) studies in which he...
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Published: |
Frontiers Media
2019
|
| _version_ | 1797064717709082624 |
|---|---|
| author | van Den Hoogen, L Walk, J Oulton, T Reuling, I Reiling, L Beeson, J Coppel, R Singh, S Draper, S Bousema, T Drakeley, C Sauerwein, R Tetteh, K |
| author_facet | van Den Hoogen, L Walk, J Oulton, T Reuling, I Reiling, L Beeson, J Coppel, R Singh, S Draper, S Bousema, T Drakeley, C Sauerwein, R Tetteh, K |
| author_sort | van Den Hoogen, L |
| collection | OXFORD |
| description | The majority of malaria infections in low transmission settings remain undetectable by conventional diagnostics. A powerful model to identify antibody responses that allow accurate detection of recent exposure to low-density infections is controlled human malaria infection (CHMI) studies in which healthy volunteers are infected with the Plasmodium parasite. We aimed to evaluate antibody responses in malaria-naïve volunteers exposed to a single CHMI using a custom-made protein microarray. All participants developed a blood-stage infection with peak parasite densities up to 100 parasites/μl in the majority of participants (50/54), while the remaining four participants had peak densities between 100 and 200 parasites/μl. There was a strong correlation between parasite density and antibody responses associated with the most reactive blood-stage targets 1 month after CHMI (Etramp 5, GLURP-R2, MSP4 and MSP1-19; Spearman’s ρ = 0.82, p < 0.001). Most volunteers developed antibodies against a potential marker of recent exposure: Etramp 5 (37/45, 82%). Our findings justify validation in endemic populations to define a minimum set of antigens needed to detect exposure to natural low-density infections. |
| first_indexed | 2024-03-06T21:18:20Z |
| format | Journal article |
| id | oxford-uuid:40914936-7688-4c92-bb9a-38a3813b2300 |
| institution | University of Oxford |
| last_indexed | 2024-03-06T21:18:20Z |
| publishDate | 2019 |
| publisher | Frontiers Media |
| record_format | dspace |
| spelling | oxford-uuid:40914936-7688-4c92-bb9a-38a3813b23002022-03-26T14:38:44ZAntibody responses to antigenic targets of recent exposure are associated with low-density parasitemia in controlled human plasmodium falciparum infectionsJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:40914936-7688-4c92-bb9a-38a3813b2300Symplectic Elements at OxfordFrontiers Media2019van Den Hoogen, LWalk, JOulton, TReuling, IReiling, LBeeson, JCoppel, RSingh, SDraper, SBousema, TDrakeley, CSauerwein, RTetteh, KThe majority of malaria infections in low transmission settings remain undetectable by conventional diagnostics. A powerful model to identify antibody responses that allow accurate detection of recent exposure to low-density infections is controlled human malaria infection (CHMI) studies in which healthy volunteers are infected with the Plasmodium parasite. We aimed to evaluate antibody responses in malaria-naïve volunteers exposed to a single CHMI using a custom-made protein microarray. All participants developed a blood-stage infection with peak parasite densities up to 100 parasites/μl in the majority of participants (50/54), while the remaining four participants had peak densities between 100 and 200 parasites/μl. There was a strong correlation between parasite density and antibody responses associated with the most reactive blood-stage targets 1 month after CHMI (Etramp 5, GLURP-R2, MSP4 and MSP1-19; Spearman’s ρ = 0.82, p < 0.001). Most volunteers developed antibodies against a potential marker of recent exposure: Etramp 5 (37/45, 82%). Our findings justify validation in endemic populations to define a minimum set of antigens needed to detect exposure to natural low-density infections. |
| spellingShingle | van Den Hoogen, L Walk, J Oulton, T Reuling, I Reiling, L Beeson, J Coppel, R Singh, S Draper, S Bousema, T Drakeley, C Sauerwein, R Tetteh, K Antibody responses to antigenic targets of recent exposure are associated with low-density parasitemia in controlled human plasmodium falciparum infections |
| title | Antibody responses to antigenic targets of recent exposure are associated with low-density parasitemia in controlled human plasmodium falciparum infections |
| title_full | Antibody responses to antigenic targets of recent exposure are associated with low-density parasitemia in controlled human plasmodium falciparum infections |
| title_fullStr | Antibody responses to antigenic targets of recent exposure are associated with low-density parasitemia in controlled human plasmodium falciparum infections |
| title_full_unstemmed | Antibody responses to antigenic targets of recent exposure are associated with low-density parasitemia in controlled human plasmodium falciparum infections |
| title_short | Antibody responses to antigenic targets of recent exposure are associated with low-density parasitemia in controlled human plasmodium falciparum infections |
| title_sort | antibody responses to antigenic targets of recent exposure are associated with low density parasitemia in controlled human plasmodium falciparum infections |
| work_keys_str_mv | AT vandenhoogenl antibodyresponsestoantigenictargetsofrecentexposureareassociatedwithlowdensityparasitemiaincontrolledhumanplasmodiumfalciparuminfections AT walkj antibodyresponsestoantigenictargetsofrecentexposureareassociatedwithlowdensityparasitemiaincontrolledhumanplasmodiumfalciparuminfections AT oultont antibodyresponsestoantigenictargetsofrecentexposureareassociatedwithlowdensityparasitemiaincontrolledhumanplasmodiumfalciparuminfections AT reulingi antibodyresponsestoantigenictargetsofrecentexposureareassociatedwithlowdensityparasitemiaincontrolledhumanplasmodiumfalciparuminfections AT reilingl antibodyresponsestoantigenictargetsofrecentexposureareassociatedwithlowdensityparasitemiaincontrolledhumanplasmodiumfalciparuminfections AT beesonj antibodyresponsestoantigenictargetsofrecentexposureareassociatedwithlowdensityparasitemiaincontrolledhumanplasmodiumfalciparuminfections AT coppelr antibodyresponsestoantigenictargetsofrecentexposureareassociatedwithlowdensityparasitemiaincontrolledhumanplasmodiumfalciparuminfections AT singhs antibodyresponsestoantigenictargetsofrecentexposureareassociatedwithlowdensityparasitemiaincontrolledhumanplasmodiumfalciparuminfections AT drapers antibodyresponsestoantigenictargetsofrecentexposureareassociatedwithlowdensityparasitemiaincontrolledhumanplasmodiumfalciparuminfections AT bousemat antibodyresponsestoantigenictargetsofrecentexposureareassociatedwithlowdensityparasitemiaincontrolledhumanplasmodiumfalciparuminfections AT drakeleyc antibodyresponsestoantigenictargetsofrecentexposureareassociatedwithlowdensityparasitemiaincontrolledhumanplasmodiumfalciparuminfections AT sauerweinr antibodyresponsestoantigenictargetsofrecentexposureareassociatedwithlowdensityparasitemiaincontrolledhumanplasmodiumfalciparuminfections AT tettehk antibodyresponsestoantigenictargetsofrecentexposureareassociatedwithlowdensityparasitemiaincontrolledhumanplasmodiumfalciparuminfections |